http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CZ-20001436-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0efa077d881a96aeb1e29b21ef1bbb58 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4523 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D275-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 |
| filingDate | 1998-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0b9f40ec42275cc5f14f02181959d45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53eea07040e8455bbbf6e6e5ce0a4c24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5af29c4e1ea7d25b46a3b06218b379a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a72063d7f1c9bdcf64d4813b6062ddb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab4b95f0291fec504f6fb70a9ca109c6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c4a3a76bd80e2a65c5ce334bf0fcab0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b74f11fb17beb893fd79018de1174898 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_480f7c54fbd8a192ab8827c550eaa62d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7b33a3ade3355787509887a0514c877 |
| publicationDate | 2000-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CZ-20001436-A3 |
| titleOfInvention | Disubstituted 1,2-benzisothiazole derivatives and their use |
| abstract | The present invention relates to disubstituted 1,2-benzisothiazole derivativesnof formula I wherein R 1, R 2 independently of one another are (C 1-6) alkyl, Anis (C 1-10) alkylene which includes at least one Z group,nconsisting of O, S, NR 7, cyclopropyl, CHOH and double orntriple bond, B denotes 4-piperidine 4-tatrahydro-1,2,3,6-npyridine, 4-piperazine and the corresponding cyclic compoundsnwith methylene groups, with binding to Anastacianwith the nitrogen atom of B and Ar denotes phenyl optionallynsubstituted with: (C 1-6 -alkyl, O- (C 1-6) -alkyl, OH, F,nCl, Br, I, trifluoromethyl, NR 5 R 6, CO> R 7, cyano or phenyl; furtherntetralin, indane, condensable at high temperaturesnaromatics such as naphthalene, which is optionally substitutednsubstituents: (C 1-4) -alkyl or O- (C 1-6) -alkyl; anthracenenor 5- or 6-membered aromatic heterocycles having 1 to 2nheteroatoms which are independently O and N, which are independently of one anothernthey may be annealed by other aromatic radicalsnfor example, quinoline, isoquinoline, counterlazine, indole, and the likenquinazoline, which may again be substituted with phenyl.nThe compounds are used in the manufacture of medicaments for the treatment of depression and the like. |
| priorityDate | 1998-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 181.